Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 221,894,020 papers from all fields of science
Search
Sign In
Create Free Account
2',6'-dimethylphenylalanine
Known as:
Dmp cpd
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Phenylalanine
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
[Dmt(1)]DALDA analogues with enhanced μ opioid agonist potency and with a mixed μ/κ opioid activity profile.
Longxiang Bai
,
Ziyuan Li
,
+4 authors
P. Schiller
Bioorganic & Medicinal Chemistry
2014
Corpus ID: 24722578
2005
2005
ORL1 and opioid receptor preferences of nociceptin and dynorphin A analogues with Dmp substituted for N-terminal aromatic residues.
Y. Sasaki
,
Susumu Kawano
,
Hirokazu Kohara
,
Hideko Watanabe
,
A. Ambo
Bioorganic & Medicinal Chemistry
2005
Corpus ID: 7146642
2004
2004
2',6'-dimethylphenylalanine (Dmp) can mimic the N-terminal Tyr in opioid peptides.
Y. Sasaki
,
A. Sasaki
,
+5 authors
A. Ambo
Biological and Pharmaceutical Bulletin
2004
Corpus ID: 24717944
Substitution of 2',6'-dimethyltyrosine (Dmt) for the N-terminal Tyr in opioid peptides has recently been shown to be a promising…
Expand
2003
2003
Dermorphin tetrapeptide analogues with 2',6'-dimethylphenylalanine (Dmp) substituted for aromatic amino acids have high mu opioid receptor binding and biological activities.
A. Ambo
,
Hideko Niizuma
,
A. Sasaki
,
Hirokazu Kohara
,
Y. Sasaki
Bioorganic & Medicinal Chemistry Letters
2003
Corpus ID: 23650490
2001
2001
Enkephalin analogues with 2',6'-dimethylphenylalanine replacing phenylalanine in position 4.
Y. Sasaki
,
Mariko Hirabuki
,
A. Ambo
,
H. Ouchi
,
Yutaka Yamamoto
Bioorganic & Medicinal Chemistry Letters
2001
Corpus ID: 20481773
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE